Quanterix Corp
For the period ended Sep 30, 2024. Filed Dec 26, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2024 · Filed Dec 26, 2024
QTRX$3.28-3.0%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Cash Flows
| Nine Months Ended September 30, | ||
|---|---|---|
| 2024 | 2023 | |
| (As Restated) | ||
| Cash flows from operating activities: | ||
| Net loss | $(26,903) | $(19,541) |
| Adjustments to reconcile net loss to net cash used in operating activities: | ||
| Depreciation and amortization expense | 4,740 | 4,843 |
| Credit losses on accounts receivable | 744 | 311 |
| Accretion of marketable securities | (5,317) | (1,490) |
| Operating lease right-of-use asset amortization | 1,371 | 1,518 |
| Stock-based compensation expense | 15,150 | 12,497 |
| Impairment | — | 130 |
| Other operating activity | (389) | 647 |
| Changes in assets and liabilities: | ||
| Accounts receivable | (6,402) | (5,615) |
| Inventory | (6,845) | (3,700) |
| Prepaid expenses and other current assets | (168) | (2,829) |
| Other non-current assets | (479) | (702) |
| Accounts payable | 588 | 948 |
| Accrued compensation and benefits, accrued expenses, and other current liabilities | (3,166) | 1,229 |
| Deferred revenue | (826) | 894 |
| Operating lease liabilities | (2,971) | (1,690) |
| Other non-current liabilities | 11 | (107) |
| Net cash used in operating activities | (30,862) | (12,657) |
| Cash flows from investing activities: | ||
| Purchases of marketable securities | (270,972) | (125,200) |
| Proceeds from maturities of marketable securities | 159,279 | — |
| Purchases of property and equipment | (2,956) | (1,878) |
| Net cash used in investing activities | (114,649) | (127,078) |
| Cash flows from financing activities: | ||
| Proceeds from common stock issued under stock plans | 2,999 | 2,632 |
| Payments for employee taxes withheld on stock-based compensation awards | (2,584) | (142) |
| Net cash provided by financing activities | 415 | 2,490 |
| Net decrease in cash, cash equivalents, and restricted cash | (145,096) | (137,245) |
| Effect of exchange rate changes on cash, cash equivalents, and restricted cash | 18 | (229) |
| Cash, cash equivalents, and restricted cash at beginning of period | 177,026 | 341,337 |
| Cash, cash equivalents, and restricted cash at end of period | $31,948 | $203,863 |
| Supplemental disclosure of cash flow information: | ||
| Cash paid for taxes | $703 | $719 |
| Shares received as consideration under product sales agreement | $— | $775 |
| Purchases of property and equipment in accounts payable and accrued expenses | $782 | $— |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.